Live from the NIH registry
Studies recruiting near Fontana right now
Top 25 of 1,013 recruiting studies, sorted by proximity — each links to its official registry page
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
Loma Linda University Medical Center (Adults only) — Loma Linda, California (11.9 mi)
· Sponsor: Pierre Fabre Medicament
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Chronic Graft-versus-host-disease
Phase 2
Interventional 296 participants sought
City of Hope — Duarte, California (29.7 mi)
· Sponsor: Syndax Pharmaceuticals
Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin Lymphoma
B-Cell Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma
Phase 1
Interventional 15 participants sought
City of Hope Medical Center — Duarte, California (29.7 mi)
· Sponsor: City of Hope Medical Center
Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
Age-Related Macular Degeneration, Geographic Atrophy
N/A
Interventional 125 participants sought
Loma Linda University — Loma Linda, California (11.9 mi)
· Sponsor: VisionCare, Inc.
Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
Neuromyelitis Optica Spectrum Disorder
Phase 2
Interventional 15 participants sought
Loma Linda University Children's Hospital - PIN — Loma Linda, California (11.9 mi)
· Sponsor: Amgen
Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset
Infant, Extremely Premature, Obstetric Labor, Premature
N/A
Observational 5,000 participants sought
Loma Linda University Children's Hospital — Loma Linda, California (11.9 mi)
· Sponsor: The University of Texas Health Science Center, Houston
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Loma Linda University Medical Center — Loma Linda, California (11.9 mi)
· Sponsor: National Cancer Institute (NCI)
Study With [225Ac]Ac-FL-020 in mCRPC Participants
Metastatic Castration-resistant Prostate Cancer
Phase 1
Interventional 50 participants sought
City of Hope Medical Center — Duarte, California (29.7 mi)
· Sponsor: Full-Life Technologies UK Limited
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Loma Linda University Medical Center — Loma Linda, California (11.9 mi)
· Sponsor: Medtronic MiniMed, Inc.
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
Ovarian Cancer
Phase 1
Interventional 285 participants sought
City of Hope National Medical Center /ID# 281381 — Duarte, California (29.7 mi)
· Sponsor: AbbVie
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Multiple Myeloma, Relapsed/Refractory Multiple Myeloma
Phase 2
Interventional 100 participants sought
City of Hope — Duarte, California (29.7 mi)
· Sponsor: C4 Therapeutics, Inc.
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
Multiple Myeloma
Phase 1
Interventional 127 participants sought
City of Hope National Medical Center /ID# 280273 — Duarte, California (29.7 mi)
· Sponsor: AbbVie
Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma
Folliculotropic Mycosis Fungoides, Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma
Phase 1, Phase 2
Interventional 78 participants sought
City of Hope Medical Center — Duarte, California (29.7 mi)
· Sponsor: City of Hope Medical Center
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
Carcinoma, Non-Small-Cell Lung
Phase 1, Phase 2
Interventional 450 participants sought
City of Hope ( Site 0014) — Duarte, California (29.7 mi)
· Sponsor: Merck Sharp & Dohme LLC
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Spinal Muscular Atrophy (SMA)
N/A
Observational 700 participants sought
Loma Linda University Health — Loma Linda, California (11.9 mi)
· Sponsor: Novartis Pharmaceuticals
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
Loma Linda University Medical Center — Loma Linda, California (11.9 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Phase 2
Interventional 120 participants sought
Inland Empire Clinical Trials — Rialto, California (5.2 mi)
· Sponsor: Regeneron Pharmaceuticals
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 1
Interventional 15 participants sought
City of Hope Medical Center — Duarte, California (29.7 mi)
· Sponsor: City of Hope Medical Center
An Observational Study to Learn More About How Well Damoctocog Alfa Pegol Works in Previously Treated Children With Hemophilia A
Hemophilia A
N/A
Observational 40 participants sought
Loma Linda University Health — Loma Linda, California (11.9 mi)
· Sponsor: Bayer
Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
Multiple conditions
Phase 1
Interventional 39 participants sought
City of Hope Comprehensive Cancer Center — Duarte, California (29.7 mi)
· Sponsor: National Cancer Institute (NCI)
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Acute Myeloid Leukemias
Phase 3
Interventional 468 participants sought
Clinical Trial Site — Duarte, California (29.7 mi)
· Sponsor: Syndax Pharmaceuticals
Duvelisib Maintenance for the Treatment of Peripheral T-Cell Lymphomas
Follicular Helper T-Cell Lymphoma, Peripheral T-Cell Lymphoma, Not Otherwise Specified
Phase 2
Interventional 25 participants sought
City of Hope Medical Center — Duarte, California (29.7 mi)
· Sponsor: City of Hope Medical Center
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Pancreatic Cancer, Pancreatic Cancer Metastatic
Phase 3
Interventional 570 participants sought
City of Hope — Duarte, California (29.7 mi)
· Sponsor: Immuneering Corporation
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
Thyroid Gland Nodule
N/A
Observational 22 participants sought
City of Hope Medical Center — Duarte, California (29.7 mi)
· Sponsor: City of Hope Medical Center
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)
Phase 1
Interventional 248 participants sought
City of Hope — Duarte, California (29.7 mi)
· Sponsor: Nurix Therapeutics, Inc.